SecurityMBII / Marrone Bio Innovations, Inc. (57165B106)
CEOMarrone Pamela G
IndustryAgricultural Chemicals
Institutional Owners45
Institutional Shares25,696,899 - 23.24%
Common Shares Outstanding110,588,949 shares (as of 2018-06-30)
Institutional Value$ 45,827,000 USD

Institutional Stock Ownership and Shareholders()

MBII / Marrone Bio Innovations, Inc. Institutional Ownership

Marrone Bio Innovations, Inc. (NASDAQ:MBII) has 45 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,696,899 shares. Largest shareholders include Ardsley Advisory Partners, Waddell & Reed Financial Inc, BlackRock Inc., Primecap Management Co/ca/, Vanguard Group Inc, State Street Corp, Northern Trust Corp, Geode Capital Management, Llc, Icm Asset Management Inc/wa, and Morgan Stanley.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-10 13F-HR Legal & General Group Plc 8,134 15
2018-08-14 13F-HR NORTHERN TRUST CORP 31,936 512,232 1,503.93 64 943 1,373.44
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,200 1,200 0.00 2 2 0.00
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 27,290 50
2018-07-12 13F-HR OGOREK ANTHONY JOSEPH /NY/ /ADV 300 0 -100.00 0 0
2018-07-30 13F-HR Taylor, Cottrill, Erickson & Associates, Inc. 15,000 15,000 0.00 30 28 -6.67
2018-08-14 13F-HR STATE STREET CORP 10,800 807,871 7,380.29 22 1,486 6,654.55
2018-08-08 13F-HR Spark Investment Management LLC 0 90,100 0 165
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 17,851 0 -100.00 36 0 -100.00
2018-08-14 13F-HR Invesco Ltd. 35,148 65
2018-08-10 13F-HR CITIGROUP INC 0 10,778 0 20
2018-08-14 13F-HR CREDIT SUISSE AG/ 0 14,054 0 26
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 947 2
2018-08-08 13F-HR Capital Planning Advisors, LLC 33,079 0 -100.00 66 0 -100.00
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 10,102 10,258 1.54 20 19 -5.00
2018-08-14 13F-HR MORGAN STANLEY 480 116,907 24,255.62 1 215 21,400.00
2018-08-09 13F-HR BlackRock Inc. 77,806 2,694,051 3,362.52 156 4,957 3,077.56
2018-08-08 13F-HR Hanson McClain, Inc. 10,000 12,766 27.66 20 23 15.00
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0 83,489 0 154
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 0 21,100 0 39
2018-07-19 13F-HR Aj Wealth Strategies, Llc 0 0 0 0
2018-08-14 13F-HR ARDSLEY ADVISORY PARTNERS 10,348,247 10,348,247 0.00 12,733 13,441 5.56
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 11,061 11,061 0.00 22 20 -9.09
2018-08-02 13F-HR ICM ASSET MANAGEMENT INC/WA 250,000 460
2018-08-06 13F-HR RHUMBLINE ADVISERS 0 47,127 0 87
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 4,928 9
2018-08-06 13F-HR Bank of New York Mellon Corp 0 116,053 0 214
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 0 20,637 0 38
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 0 35,540 0 65
2018-08-14 13F-HR TEACHERS ADVISORS INC 0 75,039 0 138
2018-08-14 13F-HR JP Morgan Chase & Co 0 11,078 0 20
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 0 77,711 0 142
2018-07-19 13F-HR Carroll Financial Associates, Inc. 2,000 2,000 0.00 4 3 -25.00
2018-08-02 13F-HR Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC 3,200 3,200 0.00 6 6 0.00
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 89,410 329,928 269.01 178 607 241.01
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 0 1,785 0 3,284
2018-07-24 13F-HR MEEDER ASSET MANAGEMENT INC 524 964
2017-02-10 13F-HR BlackRock Fund Advisors 4,483 5,563 24.09 8 12 50.00
2018-08-14 13F-HR BlueCrest Capital Management Ltd 12,428 0 -100.00 25 0 -100.00
2018-08-14 13F-HR DEUTSCHE BANK AG\ 0 86,966 0 159
2018-08-14 13F-HR VANGUARD GROUP INC 1,045,047 2,251,404 115.44 2,090 4,142 98.18
2018-05-16 13F-HR Laurel Wealth Advisors, Inc. 20,000 40
2018-08-14 13F-HR WADDELL & REED FINANCIAL INC 24,714,892 4,714,892 -80.92 47,321 8,574 -81.88
2018-08-14 13F-HR ROYAL BANK OF CANADA 0 62 0 0
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 0 83,774 0 154
2018-08-14 13F-HR BARCLAYS PLC 20,200 4,004 -80.18 40 7 -82.50
2018-08-13 13F-HR PRIMECAP MANAGEMENT CO/CA/ 2,625,600 2,625,600 0.00 5,251 4,831 -8.00
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 0 101,700 0 188
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 388 0 1
2018-08-14 13F-HR UBS Group AG 2,801 6,363 127.17 6 12 100.00

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Marrone Bio Innovations, Inc. (MBII) CEO Pam Marrone on Q2 2018 Results - Earnings Call Transcript

23h seekingalpha
Good day, and welcome to the Marrone Bio Innovations Second Quarter 2018 Earnings Conference Call. Today's conference is being recorded. (0-1)

Can Lithium Help Albemarle (ALB) Beat Earnings Again in Q2?

2018-08-03 zacks
Albemarle Corporation (ALB - Free Report) will release its second-quarter 2018 results after the bell on Aug 7. Albemarle saw its profits surge in the first quarter, buoyed by strong gains in its Lithium unit. The company posted a profit of $131.8 million or $1.18 per share in the quarter, a roughly two-and-a-half fold jump on a year over year basis. Adjusted earnings of $1.30 per share for the quarter outstripped the Zacks Consensus Estimate of $1. (5-0)

Marrone Bio Innovations (MBII) Investor Presentation - Slideshow

2018-07-27 seekingalpha
The following slide deck was published by Marrone Bio Innovations, Inc. in conjunction with this event.

Marrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Marrone Bio Innovations, Inc. (NASDAQ:MBII) Q1 2018 Results Conference Call May 10, 2018 4:30 AM ET (0-3)

Marrone Bio (MBII) Q1 Earnings In Line, Revenues Rise Y/Y

2018-05-11 zacks
Marrone Bio Innovations, Inc. (MBII - Free Report) logged a net loss of $2.9 million or 4 cents per share in first-quarter 2018, narrower than a loss of $7.6 million or 31 cents per share a year ago. Loss per share for the reported quarter was in line with the Zacks Consensus Estimate. The narrower year-over-year loss was mainly due to a gain on the conversion of debt. (383-0)

CUSIP: 57165B106